Want to join the conversation?
Provider of online accounting software $INTU posted lower 4Q16 earnings due to higher R&D and G&A expenses. Net loss was $40MM or $0.16 loss per share vs. net income of $14MM or $0.05 per diluted share in 4Q15. Revenue rose 8% to $754MM vs. 4Q15, helped by higher revenue results in Small Business and Consumer Tax and ProConnect segments.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.